Strasbourg, France

William Higgins

This inventor holds 1 USPTO granted patent. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Higgins. Retrieved from https://idiyas.com/inventor/william-higgins-nuxeifwi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William Higgins

Introduction

William Higgins is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of chemistry, particularly in the development of antibacterial agents. His work has implications for both medical and pharmaceutical applications.

Latest Patents

Higgins holds a patent for "Derivatives of 2,6-diamino-3-haloheptanedioic acid." This invention relates to amino acid, dipeptide, and tripeptide derivatives of 2,6-diamino-3-haloheptanedioic acids. The processes for preparing these derivatives and their use as antibacterial agents highlight the innovative nature of his work. He has 1 patent to his name.

Career Highlights

William Higgins has had a successful career at Merrell Dow Pharmaceuticals. His role in the company has allowed him to focus on research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding of antibacterial compounds.

Collaborations

Higgins has collaborated with notable colleagues such as Ekkehard H Bohme and Fritz E Gerhart. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

William Higgins is a distinguished inventor whose work in the field of antibacterial agents has made a significant impact. His patent and collaborations reflect his commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…